Skip to main content
OpenTrials
Completed

NCT Number: NCT03820167

Mitochondrial DNA in Fresh Versus Frozen Embryo Culture Media of PCOS Women Undergoing In Vitro Fertilization

Ninety women with PCOS candidate for ICSI were randomized to 2 groups:Group A: fresh samples of PCOS patients undergoing IVF (no= 45) and Group B: frozen samples of PCOS patients undergoing IVF (no= 45). Morphologically good embryos will be cultured in a culture dish and the supernatants will be collected freshly from culture system at day 3 and stored at -20 ̊ c until being tested. Morphologically good embryos scheduled for freezing will be cryopreserved for less than one year and thawed, the supernatant will be collected and stored at -20 ̊ c until being tested. Quantification of mtDNA in fresh and frozen culture media using qPCR technique.The template DNA prepared and the dilution standards prepared will be used for qPCR to determine the amount of MtDNA and nuclear DNA in the sample using QuantiTect SYBR Green PCR Kit

Completed

Looking for future studies?

Notify Me

Key information

About this study

Ninety women with PCOS candidate for ICSI were randomized to 2 groups:Group A: fresh samples of PCOS patients undergoing IVF (no= 45) and Group B: frozen samples of PCOS patients undergoing IVF (no= 45). Morphologically good embryos will be cultured in a culture dish and the supernatants will be collected freshly from culture system at day 3 and stored at -20 ̊ c until being tested. Morphologically good embryos scheduled for freezing will be cryopreserved for less than one year and thawed, the supernatant will be collected and stored at -20 ̊ c until being tested. Quantification of mtDNA in fresh and frozen culture media using qPCR technique.The template DNA prepared and the dilution standards prepared will be used for qPCR to determine the amount of MtDNA and nuclear DNA in the sample using QuantiTect SYBR Green PCR Kit (Qiagen)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age: 20-35 yrs.
  • BMI: ≤25.
  • PCO: diagnosed by Rotterdam criteria (at least two of the following):
  • Polycystic ovary morphology with one ovary being sufficient for diagnosis.
  • Hyperandrogenism: clinically or biochemically.
  • Anovulation or oligo-ovulation.
  • Gravidity and parity: Nulligravida.
  • Compliance: primary infertility

Exclusion criteria

  • Known medical problems as diabetes mellitus, hypertension, cardiac, hepatic or renal problem.
  • Special habits of medical importance as smoking.
  • Other endocrinopathies

Treatment and study plan

Primary outcomes

  1. clinical pregnancy rate

    Time frame: 4 weeks after embryo transfer

    detection of intrauterine gestational sac by transvaginal ultrasound

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Official study title

Mitochondrial DNA in Fresh Versus Frozen Embryo Culture Media of Polycystic Ovarian Syndrome Patients Undergoing In Vitro Fertilization

Important dates

Study start
2019
Primary completion
2019
Study completion
2020
First posted
Jan 29, 2019
Registry last updated
Feb 26, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.